Φορτώνει......
A clinical case of 3-year highly efficient pembrolizamable therapy of metasatic lung adenocarcinoma
Immunotherapy presents a new promising approach to the treatment of disseminated lung cancer. Pemriblisumab (Kitruda®) is one of the antiPD-1 drugs registered in Russia, which is used in both the secondand, in the event of high-level PD-L1 expression (≥50%), the first-line therapy. This paper presen...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , , , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Russo |
| Έκδοση: |
Remedium Group LLC
2018-07-01
|
| Σειρά: | Медицинский совет |
| Θέματα: | |
| Διαθέσιμο Online: | https://www.med-sovet.pro/jour/article/view/2526 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|